Albemarle Corporation is a global specialty chemicals leader, focusing on lithium and bromine. It operates in Energy Storage, Specialties, and Ketjen divisions, with a $20.82 billion market cap. Q4 results for fiscal 2025 are expected on Feb. 11, with analysts predicting a favorable bottom-line trajectory.

Analysts anticipate a $0.62 per share loss for Q4, a 43.1% improvement YOY. Albemarle often beats consensus estimates, with a predicted diluted EPS of $1.64 in fiscal 2026. A rebound in lithium prices has boosted stock performance, with a 91.7% gain in the past 52 weeks, outperforming the S&P 500.

Third-quarter results for fiscal 2025 exceeded estimates, with net sales at $1.31 billion. Despite a 3.5% decline in sales due to lower pricing, volume growth in Energy Storage and Ketjen segments offset the impact. Analysts are bullish on Albemarle’s future, with a consensus rating of “Moderate Buy” and a mean price target of $144.21.

Read more at Yahoo Finance: Albemarle’s Q4 2025 Earnings: What to Expect